Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
- PMID: 32146694
- PMCID: PMC7088568
- DOI: 10.1007/s11427-020-1661-4
Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
Abstract
Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged.
Keywords: COVID-19; China; asymptomatic infections; close contact.
Conflict of interest statement
Comment in
-
Implications of underrecognition of smell and taste as a symptom of COVID-19 infection.QJM. 2021 Nov 13;114(9):681-682. doi: 10.1093/qjmed/hcab017. QJM. 2021. PMID: 33486515 Free PMC article. No abstract available.
Similar articles
-
Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China.Ann Am Thorac Soc. 2020 Oct;17(10):1231-1237. doi: 10.1513/AnnalsATS.202004-324OC. Ann Am Thorac Soc. 2020. PMID: 32692945 Free PMC article.
-
An uncommon manifestation of COVID-19 pneumonia on CT scan with small cavities in the lungs: A case report.Medicine (Baltimore). 2020 Jul 10;99(28):e21240. doi: 10.1097/MD.0000000000021240. Medicine (Baltimore). 2020. PMID: 32664179 Free PMC article.
-
First Mildly Ill, Nonhospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States-Maricopa County, Arizona, 2020.Clin Infect Dis. 2020 Jul 28;71(15):807-812. doi: 10.1093/cid/ciaa374. Clin Infect Dis. 2020. PMID: 32240285 Free PMC article.
-
Clinical characteristics of family-clustered onset of coronavirus disease 2019 in Jilin Province, China.Virulence. 2020 Dec;11(1):1240-1249. doi: 10.1080/21505594.2020.1816075. Virulence. 2020. PMID: 32930632 Free PMC article. Review.
-
COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission.Int J Biol Sci. 2020 Aug 27;16(15):2803-2811. doi: 10.7150/ijbs.48991. eCollection 2020. Int J Biol Sci. 2020. PMID: 33061797 Free PMC article. Review.
Cited by
-
Insights into SARS-CoV-2 Surveillance among Prison Populations in Mato Grosso do Sul, Brazil, in 2022.Viruses. 2024 Jul 16;16(7):1143. doi: 10.3390/v16071143. Viruses. 2024. PMID: 39066305 Free PMC article.
-
A Retrospective Study of the Epidemiologic and Clinical Characteristics of COVID-19 Among Hospitalized Patients in Quanzhou, China.Infect Microbes Dis. 2021 Jan 15;3(1):32-40. doi: 10.1097/IM9.0000000000000048. eCollection 2021 Mar. Infect Microbes Dis. 2021. PMID: 38630071 Free PMC article.
-
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.Reumatol Clin. 2021 Aug-Sep;17(7):371-375. doi: 10.1016/j.reuma.2020.05.001. Epub 2020 May 16. Reumatol Clin. 2021. PMID: 38620275 Free PMC article.
-
A mathematical model for the transmission of co-infection with COVID-19 and kidney disease.Sci Rep. 2024 Mar 7;14(1):5680. doi: 10.1038/s41598-024-56399-2. Sci Rep. 2024. PMID: 38454115 Free PMC article.
-
Mitigating the COVID-19 Pandemic through Data-Driven Resource Sharing.Nav Res Logist. 2024 Feb;71(1):41-63. doi: 10.1002/nav.22117. Epub 2023 Apr 29. Nav Res Logist. 2024. PMID: 38406181
References
-
- China, N.H.C.o.t.P.s.R.o. New coronavirus pneumonia prevention and control program. 5th 2020.
-
- Ding, L., Cai, W., Jing J.Q., Zhang, X.X., Cai Y., Shi, J.W., Liang, Q.M., Zhang, L.F., Sun, L.Z., Qu, J.M., et al. (2020). An interim review of lessons from the novel coronavirus (SARS-CoV-2) outbreak in China. Sci Sin Vitae 50, doi: 10.1360/SSV-2020-0044.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials

